Ensuring a patient’s cell and gene therapy goes the distance with perfect last-mile logistics
.jpg?h=666&iar=0&w=1000&hash=AFA67235B18610400F4B9E6B12F6D06F)
Cancer can be a devastating diagnosis for a patient, with the disease and traditional treatments having a significant impact on their quality of life. Global diagnoses are on the rise; with 27.5 million new cases of cancer expected each year by 20401.
Across the world, innovators are working to introduce CGTs to fight cancers and other chronic, life-threatening conditions. Also known to the life science industry and regulators as advanced therapy medicinal products (ATMPs), these cutting-edge treatments are proving to enhance the quality and efficacy of cancer patient care and hopefully, even provide a cure for their condition.
In this case study, discover how Nagaraj*, a young man living near Bengaluru, India and fighting a rare cancer was able to receive a ground-breaking autologous T-cell-based immunotherapy developed in Malaysia thanks to the logistics expertise of World Courier.
References
* An alias to protect the patient's privacy
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.